BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12672062)

  • 1. A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein.
    Giannakis E; Jokiranta TS; Male DA; Ranganathan S; Ormsby RJ; Fischetti VA; Mold C; Gordon DL
    Eur J Immunol; 2003 Apr; 33(4):962-9. PubMed ID: 12672062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple ligand binding sites on domain seven of human complement factor H.
    Giannakis E; Male DA; Ormsby RJ; Mold C; Jokiranta TS; Ranganathan S; Gordon DL
    Int Immunopharmacol; 2001 Mar; 1(3):433-43. PubMed ID: 11367528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.
    Perkins SJ; Goodship TH
    J Mol Biol; 2002 Feb; 316(2):217-24. PubMed ID: 11851332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H.
    Blackmore TK; Fischetti VA; Sadlon TA; Ward HM; Gordon DL
    Infect Immun; 1998 Apr; 66(4):1427-31. PubMed ID: 9529063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins.
    Kotarsky H; Hellwage J; Johnsson E; Skerka C; Svensson HG; Lindahl G; Sjöbring U; Zipfel PF
    J Immunol; 1998 Apr; 160(7):3349-54. PubMed ID: 9531294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H.
    Hellwage J; Jokiranta TS; Friese MA; Wolk TU; Kampen E; Zipfel PF; Meri S
    J Immunol; 2002 Dec; 169(12):6935-44. PubMed ID: 12471127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the second heparin-binding domain in human complement factor H.
    Blackmore TK; Hellwage J; Sadlon TA; Higgs N; Zipfel PF; Ward HM; Gordon DL
    J Immunol; 1998 Apr; 160(7):3342-8. PubMed ID: 9531293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling.
    Aslam M; Perkins SJ
    J Mol Biol; 2001 Jun; 309(5):1117-38. PubMed ID: 11399083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration.
    Ormsby RJ; Ranganathan S; Tong JC; Griggs KM; Dimasi DP; Hewitt AW; Burdon KP; Craig JE; Hoh J; Gordon DL
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1763-70. PubMed ID: 18263814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pinpointing the putative heparin/sialic acid-binding residues in the 'sushi' domain 7 of factor H: a molecular modeling study.
    Ranganathan S; Male DA; Ormsby RJ; Giannakis E; Gordon DL
    Pac Symp Biocomput; 2000; ():155-67. PubMed ID: 10902165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11.
    Jarva H; Jokiranta TS; Hellwage J; Zipfel PF; Meri S
    J Immunol; 1999 Oct; 163(7):3957-62. PubMed ID: 10490997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15.
    Duthy TG; Ormsby RJ; Giannakis E; Ogunniyi AD; Stroeher UH; Paton JC; Gordon DL
    Infect Immun; 2002 Oct; 70(10):5604-11. PubMed ID: 12228288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple interactions of complement Factor H with its ligands in solution: a progress report.
    Perkins SJ; Nan R; Okemefuna AI; Li K; Khan S; Miller A
    Adv Exp Med Biol; 2010; 703():25-47. PubMed ID: 20711705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.
    McRae JL; Duthy TG; Griggs KM; Ormsby RJ; Cowan PJ; Cromer BA; McKinstry WJ; Parker MW; Murphy BF; Gordon DL
    J Immunol; 2005 May; 174(10):6250-6. PubMed ID: 15879123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations.
    Okemefuna AI; Nan R; Miller A; Gor J; Perkins SJ
    J Biol Chem; 2010 Jan; 285(2):1053-65. PubMed ID: 19850925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of the third heparin-binding site in the human complement regulator factor H1.
    Ormsby RJ; Jokiranta TS; Duthy TG; Griggs KM; Sadlon TA; Giannakis E; Gordon DL
    Mol Immunol; 2006 Apr; 43(10):1624-32. PubMed ID: 16263173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin.
    Fernando AN; Furtado PB; Clark SJ; Gilbert HE; Day AJ; Sim RB; Perkins SJ
    J Mol Biol; 2007 Apr; 368(2):564-81. PubMed ID: 17362990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46).
    Giannakis E; Jokiranta TS; Ormsby RJ; Duthy TG; Male DA; Christiansen D; Fischetti VA; Bagley C; Loveland BE; Gordon DL
    J Immunol; 2002 May; 168(9):4585-92. PubMed ID: 11971006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H.
    Blackmore TK; Sadlon TA; Ward HM; Lublin DM; Gordon DL
    J Immunol; 1996 Dec; 157(12):5422-7. PubMed ID: 8955190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.
    Jokiranta TS; Cheng ZZ; Seeberger H; Jòzsi M; Heinen S; Noris M; Remuzzi G; Ormsby R; Gordon DL; Meri S; Hellwage J; Zipfel PF
    Am J Pathol; 2005 Oct; 167(4):1173-81. PubMed ID: 16192651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.